High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

scientific article published on 01 January 1991

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.11.1.174
P698PubMed publication ID1987996

P50authorAnders HamstenQ30421754
P2093author name stringJ Johansson
L A Carlson
C Landou
P433issue1
P304page(s)174-182
P577publication date1991-01-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleHigh density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients
P478volume11

Reverse relations

cites work (P2860)
Q34559952A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice
Q35749303APOA1 gene polymorphisms in the South Asian immigrant population in the United States.
Q37074030APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training
Q73450272Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease
Q44451323Alterations of HDL subclasses in hyperlipidemia
Q79376410Alterations of high density lipoprotein subclasses in obese subjects
Q34348277Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study.
Q46170654Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis
Q43719828Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease
Q68226787Close correlation between high-density lipoprotein and triglycerides in normotriglyceridaemia
Q33795981Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.
Q46561056Comparison of high-density and low-density lipoprotein cholesterol subclasses and sizes in Asian Indian women with Caucasian women from the Framingham Offspring Study.
Q37440932Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy
Q57337160Dietary fat saturation distinctly affects apolipoprotein gene expression and high density lipoprotein size distribution in two strains of Golden Syrian hamsters
Q51166724Early atherogenesis and visceral fat in obese adolescents.
Q37189976Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women.
Q43687599Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia
Q44317936Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes
Q37307972Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome
Q44476840Effects of extended-release niacin on lipoprotein subclass distribution
Q43833266Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial
Q71858808Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia
Q33727998Endurance exercise training effects on body fatness, VO2max, HDL-C subfractions, and glucose tolerance are influenced by a PLIN haplotype in older Caucasians
Q38293451Epidemiology: disease associations and modulators of HDL-related biomarkers
Q74046180Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein
Q44631872Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography
Q37048418HDL heterogeneity and coronary heart disease
Q43889901HDL particle size: a marker of the gender difference in the metabolic risk profile
Q45936247HDL subspecies in young adult twins: heritability and impact of overweight.
Q26775420High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
Q33737098High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease
Q36959779High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.
Q51552490Hypercholesterolemia and Dyslipidemia.
Q51537186Hypercholesterolemia and Dyslipidemia: Issues for the Clinician.
Q37786770Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease
Q51557580Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women.
Q44097757Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil
Q37401325Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).
Q37089542Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study
Q36763277Lipoprotein subclasses in genetic studies: the Berkeley data set.
Q30514016Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study
Q46904300Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans
Q34990610Measurement issues related to lipoprotein heterogeneity
Q33665252Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy
Q56091366Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy
Q43687592Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
Q40343323Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein
Q33820345Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
Q44647368Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin
Q47326493Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients
Q43545506Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size
Q47987181Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.
Q49554117Pharmacological Intervention to Modulate HDL: What Do We Target?
Q54120058Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility.
Q25255948Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population
Q47644677Premature Coronary Heart Disease in South Asians: Burden and Determinants
Q36297930Preparation and activity analysis of recombinant human high-density lipoprotein
Q34003407Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment
Q33859347Prevention of coronary heart disease. Part I. Primary prevention
Q37205985Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort
Q77330990Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease
Q37661249Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.
Q68231218Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease
Q44054640Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial
Q73229439Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women
Q34732457Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
Q85811975Statin treatment improves plasma lipid levels but not HDL subclass distribution in patients undergoing percutaneous coronary intervention
Q90224960The Burden of Atherosclerotic Cardiovascular Disease in South Asians Residing in Canada: A Reflection From the South Asian Heart Alliance
Q37041300The Pleiotropic Effects of Atorvastatin on Stable Angina Patients: Evidence by Analysis of High-Density Lipoprotein Size and Subclasses, and Plasma mRNA.
Q33681012The associations of high-density lipoprotein subclasses with insulin and glucose levels, physical activity, resting heart rate, and regional adiposity in men with coronary artery disease: the Stanford Coronary Risk Intervention Project baseline surv
Q79280417The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients
Q34564466The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
Q42797558The isolation and characterization of high-density-lipoprotein subfractions containing apolipoprotein E from human plasma
Q35017376The physiology of lipoproteins
Q44804722The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL.
Q47772676The role of cholesteryl ester transfer protein and phospholipid transfer protein in the remodeling of plasma high-density lipoproteins
Q41282607Uptake of apolipoprotein E-rich and apolipoprotein E-poor subfractions of high-density lipoprotein by liver membranes and HepG2 cells
Q44316273Visualization of the uptake of high-density lipoprotein by rat aortic endothelial cells and smooth muscle cells in vitro

Search more.